ArticleBMC microbiology2021
A multispecies outbreak of carbapenem-resistant bacteria harboring the bla
Article in BMC microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 27 citations in OpenAlex.
- Genomic characterization ofMicrobiology spectrum · 2026Article
- Role of Mobilome in Carbapenem Resistance.Antibiotics (Basel, Switzerland) · 2026Review
- Epidemiological and Genomic Characteristics ofTransboundary and emerging diseases · 2026Article
- New Insights inAntibiotics (Basel, Switzerland) · 2025Article
- Detection of KPC-producing Enterobacterales species in wastewater samples from the Gran Concepción Metropolitan area, Chile.Biological research · 2025Article
- Multispecies emergence of dualAntimicrobial agents and chemotherapy · 2025Article
- Dissemination of IncQ1 Plasmids Harboring NTEMicroorganisms · 2025Article
- Decadal Evolution of KPC-related plasmids in Pseudomonas aeruginosa high-risk clone ST463 in Zhejiang, China.Communications biology · 2024Article
- Characterization of acquired β-lactamases inMicrobiology spectrum · 2024Article
- Carbapenem-resistant hypervirulent ST23 Klebsiella pneumoniae with a highly transmissible dual-carbapenemase plasmid in Chile.Biological research · 2024Article
- Antimicrobial resistance, pathogenic potential, and genomic features of carbapenem-resistantMicrobiology spectrum · 2023Article
- Worldwide Dissemination ofAntibiotics (Basel, Switzerland) · 2023Review
- Ecological dynamics of plasmid transfer and persistence in microbial communities.Current opinion in microbiology · 2022Review
- Deciphering the genetic network and programmed regulation of antimicrobial resistance in bacterial pathogens.Frontiers in cellular and infection microbiology · 2022Review
- Novel insights related to the rise of KPC-producingFrontiers in cellular and infection microbiology · 2022Article
- Acquisition of resistance to ceftazidime-avibactam during infection treatment inFrontiers in cellular and infection microbiology · 2022Article
- A Novel Multidrug Resistant, Non-TnFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundKlebsiella pneumoniae is the most frequent KPC-producing bacteria. The bla
resultsHigh-risk sequence types were found: K. pneumoniae ST11, P. aeruginosa ST654, and E. cloacae ST114. All enterobacterial isolates were not clonal except for 3 E. coli isolated from the same patient. WGS analysis in 6 enterobacterial isolates showed that 4 of them had bla
conclusionsMost enterobacterial isolates had bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.